Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (1673)	10/14/2005 9:21:25 AM
From: Ron	Respond to of 7944

Thanks for pointing AVII out. That's a classic bull pennant, either that or a bull flag, not sure there's a difference. But we have price levelling off and dipping a bit on sharply lower volume. I think we are also seeing the anti-viral potential in AVII's products. Ebola and Marburg treatments and... of course there's another virus getting a lot of attention these days. I won't say what it is.. might jinx it :) stockcharts.com[w,a]daclyyay[db][pb10!b20][vc60][iLah12,26,9!Lg]&pref=G

To: ~digs who wrote (1673)	10/16/2005 2:14:52 PM
From: Ron	Respond to of 7944

A bit more on AVII and Avian Influenza, from company release: "We believe AVI's technology, which has demonstrated an excellent pharmacokinetic and safety profile in humans, may be directed against a broad range of potential biodefense threats, and we are encouraged by the results we have seen to date," said Denis R. Burger, Ph.D., chief executive officer of AVI. "Our work with the DoD allows us to develop drugs that have an important public health impact, and we are now applying our technology to address the potential emergence of avian influenza H5N1." I suppose it could have applications both in controlling the virus in birds as well as humans, or any intermediary hosts, if they can track it down efficiently enough.